A 16 Week Study to Evaluate the Efficacy and Safety of PF-06882961 in Adults With Type 2 Diabetes Mellitus

NCT03985293 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

412

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: Placebo
DRUG: PF-06882961

Sponsor

Pfizer